Evidence map›Paper›PMID 32283920›Full record

ArticleACS combinatorial science2020

Magnetic Bead-Immobilized Mammalian Cells Are Effective Targets to Enrich Ligand-Displaying Yeast.

Patrick S Lown, Benjamin J Hackel

Open access · greenAbstract read
In one paragraph

Article in ACS combinatorial science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Patrick S LownDepartment of Chemical Engineering and Materials Science, University of Minnesota-Twin Cities, 421 Washington Avenue Southeast, 356 Amundson Hall, Minneapolis, Minnesota 55455, United States.
Benjamin J HackelDepartment of Chemical Engineering and Materials Science, University of Minnesota-Twin Cities, 421 Washington Avenue Southeast, 356 Amundson Hall, Minneapolis, Minnesota 55455, United States.ORCID 0000-0003-3561-9463
University of Minnesota · US

Funding

Engineering synthetic ligands with potent allosteric inhibition of tumornecrosis factor receptorsR01EB028274 · NIBIB · UNIVERSITY OF MINNESOTA · PI HACKEL, BENJAMIN, SACHS, JONATHAN N · 2019 to 2022
$1.5M
Engineering Gp2 as a small ligand scaffoldR01EB023339 · NIBIB · UNIVERSITY OF MINNESOTA · PI HACKEL, BENJAMIN · 2017 to 2020
$1.3M
NIBIB NIH HHS R01 EB023339NIBIB NIH HHS R01 EB028274
6 · The paper itself

Abstract

Yeast surface display empowers selection of protein binding ligands, typically using recombinant soluble antigens. However, ectodomain fragments of transmembrane targets may fail to recapitulate their true, membrane-bound form. Direct selections against adhered mammalian cells empower enrichment of genuine binders yet benefit from high target expression, robustly adherent mammalian cells, and nanomolar affinity ligands. This study evaluates a modified format with mammalian cells immobilized to magnetic beads; yeast-displayed fibronectin domain and affibody ligands of known affinities and cells with expression ranges of epidermal growth factor receptor (EGFR) and CD276 elucidate important parameters to ligand enrichment and yield in cell suspension panning with comparison to adherent panning. Cell suspension panning is hindered by significant background of nondisplaying yeast but exhibits yield advantages in model EGFR systems for a high affinity (

Indexed as

B7 AntigensCell AdhesionErbB ReceptorsHumansLigandsMagnetic PhenomenaSaccharomyces cerevisiaeTumor Cells, CulturedB7 AntigensCD276 protein, humanEGFR protein, humanErbB ReceptorsLigandsbiopanningcell suspension panningepidermal growth factor receptorligandprotein engineeringyeast display

Identifiers

PMID32283920
PMCPMC7263704
OpenAlexW3015910860

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.